ASAmber Salisbury

Amber Salisbury

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Amber Salisbury has a total of 57 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Australian perspectives towards genomics informed risk-based cancer screening programs: a focus group study

    by Deborah Di-Xin Zhou, Amber Salisbury, Renee Mostyn, Kate L. A. Dunlop, Karen Canfell, Louisa Collins, Michael Caruana, Cynthia Low, Anne E. Cust, Richard Norman, et al.

    Background: Predictions of cancer risk based on genomic data (polygenic risk scores) can stratify a population into different risk groups, allowing risk-tailored cancer screening programs. While such approaches are generally viewed as acceptable, there remain gaps in understanding Australian perceptions to guide implementation of future cancer control programs and policies. This project aimed to explore Australians’ views on using genomic information to tailor cancer screening and how such programs could be implemented. Methods: Four focus groups ( n = 28) were held using a discussion guide that explored key features at each stage of potential programs: deciding to take the test, completing the test, receiving the results, and the subsequent impact on screening. Reflexive thematic analysis was used to identify, code and report themes. Results: Three central themes emerged: (1) The value of knowing, which reflected motivations to test for personal as well as family and social benefits; (2) Navigating the complexity of genomics, highlighting challenges in understanding potential pre-test information and results; and (3) Trust in testing, providers, and government which influenced program acceptability for the initial genomic testing. However, this trust may not always result in participants following subsequent cancer screening recommendations. Conclusion: Our study identifies the need for community education and clear communication about genomics-informed risk-tailored cancer screening. Potential screening programs should consider the role of healthcare professionals and ensure they receive appropriate training to meet public needs. Further research should explore potential adherence to risk-tailored screening recommendations.

  • Open Access

    Giddy up! Can We Reduce Dropouts in a Discrete-Choice Experiment by Including an Encouraging Message? A Randomised Trial

    by Alison Pearce, Lazaros Andronis, Lauren J. Christie, Nicola Fearn, Helen M. L. Frazer, Nehmat Houssami, M. Luke Marinovich, Amber Salisbury

    Background: Discrete-choice experiments (DCEs) are valuable in establishing health preferences. However, their repetitive nature may cause dropouts. Aim: Does an encouraging ‘giddy-up’ message improve completion rates, data quality and respondent experience? Design: Two online DCEs in Australia: 1) breast cancer screening (women aged 40–75 y) and 2) arm therapy (stroke survivors aged >18 y). We randomised participants to see 10 to 12 choice sets continuously or with a social exchange theory–based giddy-up message halfway. Conditional binomial statistics compared dropout rates as our primary outcome. Secondary outcomes included completion time, difficulty and preference consistency. Results: From 867 screening and 333 stroke respondents, the dropout rates were 7% and 28%, respectively. Among those who completed >50% of the choice sets, there was no significant difference in dropout rates between arms (screening: 1.5% control, 0.75% giddy-up, P = 0.35; stroke: 1.7% control, 4.1% giddy-up, P = 0.30). There were no significant differences in secondary outcomes, except in the screening survey, in which the giddy-up reduced difficulty (5% vs 2%, P = 0.03) and improved understanding (18% vs 12%, P = 0.01). Conclusions: A DCE giddy-up message appears to have little impact on completion, although it may make the survey feel easier to complete. Implications: A giddy-up message is unlikely to be useful in online, adult DCEs.

  • Open Access

    A Method for Estimating Resource Use and Costs when Empirical Data Are Unavailable: Expert Elicitation Study Using the Example of Melanoma

    by Rob Hainsworth, Louisa Collins, Martin Eden, Adele Green, Paul Lorigan, Gabriel Rogers, Amber Salisbury, Katherine Payne

    Purpose. The diagnosis, management, and therapy of cancer are rapidly advancing and becoming more costly. Data linking the diagnosis, management, and prescription of systemic anticancer therapy (SACT) are not publicly available, are time-consuming to obtain, and are onerous to analyze. We aimed to illustrate how a simple expert elicitation method can be used rapidly to calculate the cost of diagnosing and treating a cancer by stage of disease. We illustrate the method using the example of melanoma. Methods. We designed a simple structured elicitation exercise for melanoma experts from the United Kingdom with the aim of describing the diagnosis, management, and SACT prescription for people with melanoma and the associated proportions offered each option. We modeled experts’ beliefs using scaled beta distributions. We used random-effects meta-analysis to combine the estimates. Published unit costs (£; 2024–2025) were multiplied by estimated proportions to calculate the mean costs for the diagnosis, management, and SACT by disease stage. Results. Seven dermatologists, 5 oncologists, and 4 surgeons participated (2022–2023). There was variation in the estimates of the proportions receiving possible diagnosis, management, or SACT options. Diagnosing suspicious lesions cost £424 to £699 depending on the investigations required. Mean (95% confidence intervals) management costs were £782 (£611, £981) for stage 0, £946 (£776, £1,145) for stage 1a, £4,729 (£4,532, £4,944) for stage 1b/2, £3,719 (£3,213, £4,150) for macroscopic 3, and £2,827 (£2,757, £2,904) for microscopic 3. Mean SACT costs were £65,289 (£50,581, £74,521) for stage 3 and £134,065 (£115,787, £152,938) for stage 4. Conclusions. Our new approach to eliciting and combining estimates balances practical and theoretical considerations. We illustrate how this method produces estimates of the costs, and associated uncertainty, of the diagnosis, management, and SACT for melanoma by stage of disease in the absence of readily accessible diagnosis, management, and prescribing data. These cost estimates were not validated against registry data. Highlights: Linked diagnosis, primary surgical management (hereafter “management”), and prescribing of systemic anticancer therapies (SACT) data describing the number and proportion of people with cancer offered these options are not readily available. The time to obtain data together with the time to conduct onerous analyses are a key barrier to obtaining values for use by decision analysts building economic models for evaluating new options for the early detection or prevention of cancer. We designed a simple expert elicitation exercise, completed in Excel. The exercise was designed to provide estimates of the total cost of cancer by stage of disease and crucially also to understand the extent of uncertainty around these estimates. We used melanoma as an exemplar cancer. Clinical experts (consultant dermatologists, surgeons, and oncologists) estimated the proportions of people offered possible diagnostic, management, or SACT options for melanoma (by stage of disease). Our study suggested that they found the expert elicitation exercise easy to understand and managed to complete the task. Random-effects meta-analysis used to pool the individual estimates indicated substantial heterogeneity across experts’ estimates of most elicited proportions. This finding suggested wide variation in possible approaches to the diagnosis, management, and use of SACT for melanoma.

  • Open Access

    Public Perspectives Around Prenatal Screening of Chromosomal Abnormalities: A Focus Group Study Comparing Metropolitan and Rural/Regional Areas in Australia

    by Amber Salisbury, Hovea Winston, Alexis Johnson, Alison Pearce, Kirsten Howard, Sarah Norris

    Background: The widespread and rapid adoption of private payments for non‐invasive prenatal testing (NIPT) in Australia has introduced complexities to the decision‐making process for the public regarding prenatal screening. NIPT has the potential to be a useful screening tool, but concerns have been raised about its cost, the psychological consequences of testing and the information available to support informed decision‐making. Objective: To explore the attitudes, values and beliefs around prenatal screening in Australia, and how perspectives may differ between people living in metropolitan locations versus rural/regional locations. Materials and Methods: Three focus groups were conducted in New South Wales (NSW), Australia. Participants ( N = 25) were recruited by a market research group. Focus groups took place face‐to‐face in metropolitan and rural/regional areas, and online via videoconference. Discussions were transcribed and analysed thematically. Results: Participants generally expressed interest in undertaking prenatal screening but held misconceptions about the purpose of NIPT (i.e. screening, not diagnosis) and the conditions assessed. There were varied opinions among participants on expanding the scope of screening: some felt additional information provided reassurance, whilst others thought it would increase stress due to the decreased accuracy. People living in rural/regional areas had greater concerns over access to screening (cost, wait times and distance) than people living in metropolitan areas. Conclusion: Our findings demonstrate different approaches are needed to improve understanding of NIPT (to ensure informed consent), and to improve access to NIPT for people living in rural/regional areas. The pre‐test information needs to account for the range of perspectives observed across geographic locations.


  • Open Access

    Australian Preferences for Prenatal Screening: A Discrete Choice Experiment Comparing Metropolitan and Rural/Regional Areas

    by Amber Salisbury, Sarah Norris, Alison Pearce, Kirsten Howard

    Background Non-invasive prenatal testing has the potential to be a useful genetic screening tool in Australia. However, concerns have been raised about its cost, commercial provision, the psychological impacts of the screening process, and disparities in access experienced by rural and regional communities. Aims The aims of this study are (1) to estimate Australian preferences for features of prenatal screening; (2) to explore potential variations in preferences between metropolitan and rural/regional communities; (3) to estimate the extent to which respondents are willing to trade-off between attributes, using willingness to pay (WTP) and willingness to wait estimates. Methods A discrete choice experiment (DCE) was conducted with 12 choice tasks. The DCE recruited participants from metropolitan (n = 160) and rural/regional (n = 168) locations across Australia. Mixed logit and latent class analyses were conducted and WTP and willingness to wait were calculated. Results Both metropolitan and rural/regional preferences were significantly impacted by the false-positive rate, false-negative rate, and cost. In addition, rural preferences were significantly impacted by the scope of the conditions covered, the inconclusive rate, and wait times. The number of screening tests and revealing the sex of the foetus were not significant within either group. Willingness to pay estimates ranged from AU$13 to avoid a test with a 1% increase in the false-positive rate to AU$323 to screen for a wide range of conditions. Conclusions This study highlights the importance of considering differing preferences between rural and metropolitan populations when delivering prenatal screening. Further, this study provides Australian-specific WTP estimates to be incorporated into economic evaluations.


  • Open Access

    Impact of Structural Differences on the Modeled Cost-Effectiveness of Noninvasive Prenatal Testing

    by Amber Salisbury, Alison Pearce, Kirsten Howard, Sarah Norris

    Background: Noninvasive prenatal testing (NIPT) was developed to improve the accuracy of prenatal screening to detect chromosomal abnormalities. Published economic analyses have yielded different incremental cost-effective ratios (ICERs), leading to conclusions of NIPT being dominant, cost-effective, and cost-ineffective. These analyses have used different model structures, and the extent to which these structural variations have contributed to differences in ICERs is unclear. Aim: To assess the impact of different model structures on the cost-effectiveness of NIPT for the detection of trisomy 21 (T21; Down syndrome). Methods: A systematic review identified economic models comparing NIPT to conventional screening. The key variations in identified model structures were the number of health states and modeling approach. New models with different structures were developed in TreeAge and populated with consistent parameters to enable a comparison of the impact of selected structural variations on results. Results: The review identified 34 economic models. Based on these findings, demonstration models were developed: 1) a decision tree with 3 health states, 2) a decision tree with 5 health states, 3) a microsimulation with 3 health states, and 4) a microsimulation with 5 health states. The base-case ICER from each model was 1) USD$34,474 (2023)/quality-adjusted life-year (QALY), 2) USD$14,990 (2023)/QALY, (3) USD$54,983 (2023)/QALY, and (4) NIPT was dominated. Conclusion: Model-structuring choices can have a large impact on the ICER and conclusions regarding cost-effectiveness, which may inadvertently affect policy decisions to support or not support funding for NIPT. The use of reference models could improve international consistency in health policy decision making for prenatal screening. Highlights: NIPT is a clinical area in which a variety of modeling approaches have been published, with wide variation in reported cost-effectiveness. This study shows that when broader contextual factors are held constant, varying the model structure yields results that range from NIPT being less effective and more expensive than conventional screening (i.e., NIPT was dominated) through to NIPT being more effective and more expensive than conventional screening with an ICER of USD$54,983 (2023)/QALY. Model-structuring choices may inadvertently affect policy decisions to support or not support funding of NIPT. Reference models could improve international consistency in health policy decision making for prenatal screening.


  • Open Access

    Public Preferences for Genetic and Genomic Risk-Informed Chronic Disease Screening and Early Detection: A Systematic Review of Discrete Choice Experiments

    by Amber Salisbury, Joshua Ciardi, Richard Norman, Amelia K. Smit, Anne E. Cust, Cynthia Low, Michael Caruana, Louisa Gordon, Karen Canfell, Julia Steinberg, et al.

    Purpose Genetic and genomic testing can provide valuable information on individuals’ risk of chronic diseases, presenting an opportunity for risk-tailored disease screening to improve early detection and health outcomes. The acceptability, uptake and effectiveness of such programmes is dependent on public preferences for the programme features. This study aims to conduct a systematic review of discrete choice experiments assessing preferences for genetic/genomic risk-tailored chronic disease screening. Methods PubMed, Embase, EconLit and Cochrane Library were searched in October 2023 for discrete choice experiment studies assessing preferences for genetic or genomic risk-tailored chronic disease screening. Eligible studies were double screened, extracted and synthesised through descriptive statistics and content analysis of themes. Bias was assessed using an existing quality checklist. Results Twelve studies were included. Most studies focused on cancer screening (n = 10) and explored preferences for testing of rare, high-risk variants (n = 10), largely within a targeted population (e.g. subgroups with family history of disease). Two studies explored preferences for the use of polygenic risk scores (PRS) at a population level. Twenty-six programme attributes were identified, with most significantly impacting preferences. Survival, test accuracy and screening impact were most frequently reported as most important. Depending on the clinical context and programme attributes and levels, estimated uptake of hypothetical programmes varied from no participation to almost full participation (97%). Conclusion The uptake of potential programmes would strongly depend on specific programme features and the disease context. In particular, careful communication of potential survival benefits and likely genetic/genomic test accuracy might encourage uptake of genetic and genomic risk-tailored disease screening programmes. As the majority of the literature focused on high-risk variants and cancer screening, further research is required to understand preferences specific to PRS testing at a population level and targeted genomic testing for different disease contexts.


  • Open Access

    The RETRIEVE Checklist for Studies Reporting the Elicitation of Stated Preferences for Child Health-Related Quality of Life

    by Cate Bailey, Martin Howell, Rakhee Raghunandan, Kim Dalziel, Kirsten Howard, Brendan Mulhern, Stavros Petrou, Donna Rowen, Amber Salisbury, Rosalie Viney, et al.

    Background Recent systematic reviews show varying methods for eliciting, modelling, and reporting preference-based values for child health-related quality-of-life (HRQoL) outcomes, thus producing value sets with different characteristics. Reporting in many of the reviewed studies was found to be incomplete and inconsistent, making them difficult to assess. Checklists can help to improve standards of reporting; however, existing checklists do not address methodological issues for valuing child HRQoL. Existing checklists also focus on reporting methods and processes used in developing HRQoL values, with less focus on reporting of the values’ key characteristics and properties. We aimed to develop a checklist for studies generating values for child HRQoL, including for disease-specific states and value sets for generic child HRQoL instruments. Development A conceptual model provided a structure for grouping items into five modules. Potential items were sourced from an adult HRQoL checklist review, with additional items specific to children developed using recent reviews. Checklist items were reduced by eliminating duplication and overlap, then refined for relevance and clarity via an iterative process. Long and short checklist versions were produced for different user needs. The resulting long RETRIEVE contains 83 items, with modules for reporting methods (A–D) and characteristics of values (E), for researchers planning and reporting child health valuation studies. The short RETRIEVE contains 14 items for decision makers or researchers choosing value sets. Conclusion Applying the RETRIEVE checklists to relevant studies suggests feasibility. RETRIEVE has the potential to improve completeness in the reporting of preference-based values for child HRQOL outcomes and to improve assessment of preference-based value sets.


  • Open Access

    Systematic Review of the Relative Social Value of Child and Adult Health

    by Tessa Peasgood, Martin Howell, Rakhee Raghunandan, Amber Salisbury, Marcus Sellars, Gang Chen, Joanna Coast, Jonathan C. Craig, Nancy J. Devlin, Kirsten Howard, et al.

    Objectives We aimed to synthesise knowledge on the relative social value of child and adult health. Methods Quantitative and qualitative studies that evaluated the willingness of the public to prioritise treatments for children over adults were included. A search to September 2023 was undertaken. Completeness of reporting was assessed using a checklist derived from Johnston et al. Findings were tabulated by study type (matching/person trade-off, discrete choice experiment, willingness to pay, opinion survey or qualitative). Evidence in favour of children was considered in total, by length or quality of life, methodology and respondent characteristics. Results Eighty-eight studies were included; willingness to pay (n = 9), matching/person trade-off (n = 12), discrete choice experiments (n = 29), opinion surveys (n = 22) and qualitative (n = 16), with one study simultaneously included as an opinion survey. From 88 studies, 81 results could be ascertained. Across all studies irrespective of method or other characteristics, 42 findings supported prioritising children, while 12 provided evidence favouring adults in preference to children. The remainder supported equal prioritisation or found diverse or unclear views. Of those studies considering prioritisation within the under 18 years of age group, nine findings favoured older children over younger children (including for life saving interventions), six favoured younger children and five found diverse views. Conclusions The balance of evidence suggests the general public favours prioritising children over adults, but this view was not found across all studies. There are research gaps in understanding the public’s views on the value of health gains to very young children and the motivation behind the public’s views on the value of child relative to adult health gains. Clinical Trial Registration The review is registered at PROSPERO number: CRD42021244593. There were two amendments to the protocol: (1) some additional search terms were added to the search strategy prior to screening to ensure coverage and (2) a more formal quality assessment was added to the process at the data extraction stage. This assessment had not been identified at the protocol writing stage.


  • Open Access

    Preference Elicitation Techniques Used in Valuing Children’s Health-Related Quality-of-Life: A Systematic Review

    by Cate Bailey, Martin Howell, Rakhee Raghunandan, Amber Salisbury, Gang Chen, Joanna Coast, Jonathan C. Craig, Nancy J. Devlin, Elisabeth Huynh, Emily Lancsar, et al.

    Background and Objectives Valuing children’s health states for use in economic evaluations is globally relevant and is of particular relevance in jurisdictions where a cost-utility analysis is the preferred form of analysis for decision making. Despite this, the challenges with valuing child health mean that there are many remaining questions for debate about the approach to elicitation of values. The aim of this paper was to identify and describe the methods used to value children’s health states and the specific issues that arise in the use of these methods. Methods We conducted a systematic search of electronic databases to identify studies published in English since 1990 that used preference elicitation methods to value child and adolescent (under 18 years of age) health states. Eligibility criteria comprised valuation studies concerning both child-specific patient-reported outcome measures and child health states defined in other ways, and methodological studies of valuation approaches that may or may not have yielded a value set algorithm. Results A total of 77 eligible studies were identified from which data on country setting, aims, condition (general population or clinically specific), sample size, age of respondents, the perspective that participants were asked to adopt, source of values (respondents who completed the preference elicitation tasks) and methods questions asked were extracted. Extracted data were classified and evaluated using narrative synthesis methods. The studies were classified into three groups: (1) studies comparing elicitation methods (n = 30); (2) studies comparing perspectives (n = 23); and (3) studies where no comparisons were presented (n = 26); selected studies could fall into more than one group. Overall, the studies varied considerably both in methods used and in reporting. The preference elicitation tasks included time trade-off, standard gamble, visual analogue scaling, rating/ranking, discrete choice experiments, best-worst scaling and willingness to pay elicited through a contingent valuation. Perspectives included adults’ considering the health states from their own perspective, adults taking the perspective of a child (own, other, hypothetical) and a child/adolescent taking their own or the perspective of another child. There was some evidence that children gave lower values for comparable health states than did adults that adopted their own perspective or adult/parents that adopted the perspective of children. Conclusions Differences in reporting limited the conclusions that can be formed about which methods are most suitable for eliciting preferences for children’s health and the influence of differing perspectives and values. Difficulties encountered in drawing conclusions from the data (such as lack of consensus and poor reporting making it difficult for users to choose and interpret available values) suggest that reporting guidelines are required to improve the consistency and quality of reporting of studies that value children’s health using preference-based techniques.